Navigation Links
IOC Takes Decisive Action on Ticketing Allegations
Date:6/18/2012

(PRWEB) June 18, 2012

The International Olympic Committee (IOC) has moved quickly to deal with allegations that some National Olympic Committees (NOC) and Authorised Ticket Resellers (ATR) have broken rules relating to the sale of Olympic tickets.

After claims that several NOCs and ATRs were reportedly willing to break the rules by offering to buy or sell tickets outside their territory, sell tickets at inflated prices, or sell tickets to unauthorized resellers, the IOC has ordered an immediate inquiry and referred the allegations to its independent Ethics Commission.

On being informed of the allegations, the IOC immediately convened an extraordinary meeting of its Executive Board and determined a number of actions - the convening of the Ethics Commission and asking for any evidence of wrongdoing to be provided to the Commission without delay.

The IOC takes these allegations very seriously and has immediately taken the first steps to investigate. Should any irregularities be proven, the organisation will deal with those involved in an appropriate manner. The NOCs are autonomous organisations, but if any of the cases are confirmed the IOC will not hesitate to impose the strongest sanctions.

The IOC has also determined that it will take on board any recommendations coming out of the inquiry to improve the way that tickets are allocated and sold internationally in the future.

For more information, please contact the IOC Media Relations Team.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9614604.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Violence Takes a Toll on Childrens Sleep
2. Optogenetics project takes top NIDA Addiction Science Award
3. It takes a village to keep teens substance free
4. Study: Insomnia takes toll on tinnitus patients
5. CPAP found to improve sexual function, satisfaction in men with sleep apnea
6. States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds
7. Reactions to HIV drug have autoimmune cause, reports AIDS journal
8. Study Explores Distractions Role in Pain Relief
9. Driven to distraction
10. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: